Live news related to IMPLANET stock (FR0013470168): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on IMPLANET mainly cover earnings publications, M&A activity et the dividend and payout policy. The stock trades at €0,15 on Euronext Paris, down 0,67% at the last update. This page lists the articles published on IMPLANET stock to track the share price, company announcements and any item likely to influence market perception.
The Bordeaux-based spinal surgery implant manufacturer retreats sharply during trading, following the publication of revenue growth over nine months. …
Implanet published on October 13, 2026, after market close, revenue of €10.57 million over the first nine months of 2026, compared to €8.73 million a …
Implanet published on September 15, 2026 its accounts for the first half of the current fiscal year, closed on June 30, 2026.The orthopedic implant ma…
Medical technology company IMPLANET reported a revenue of €7.13 million for the first half of 2026, up 23% year-over-year. This growth accelerated in …
IMPLANET held its Mixed General Meeting on Friday, April 17, 2026. All resolutions submitted for voting were adopted, including the renewal of the man…
IMPLANET reports a revenue of EUR 3.03 million in the first quarter of 2026, an increase of 18% compared to the same period in 2025, confirming a grow…
French spinal implant manufacturer Implanet has entered into a partnership agreement with Canadian firm 8i Robotics Inc., the company announced. This …
Implanet's stock price experienced a significant increase of 23.17% at 11 AM, reaching 0.2020 euros from 0.16 euros the previous day. This increase fo…
IMPLANET, a company specializing in spinal implants, announces the first placements of its JAZZ system in China, marking a major turning point in its …
